Skip to main content

Table 2 Comparison of outcomes among the three groups

From: Comparison of different treatment strategies in the management of endogenic caesarean scar pregnancy: a multicentre retrospective study

 

MTX group

(n = 120)

Curettage group

(n = 106)

Hysteroscopy group

(n = 221)

P value

Treatment success

103 (85.8%)

89 (84.0%)

212 (95.9%)

< 0.001

Surgery time (min)

20.0 (10.0 30.0)

20.0 (15.0 30.0)

25.0 (20.0 30.0)

0.001

Blood loss (ml)

20.0(10.0, 50.0)

20.0 (10.0 20.0)

20.0 (10.0 30.0)

0.455

Blood transfusion Yes

1 (0.8%)

3 (2.8%)

4 (1.8%)

0.513

No

119 (99.2%)

103 (97.2%)

217 (98.2%)

 

β-hCG after treatment (mIU/ml)

1462.5

(307.443757.57)

4611.00

(1125.009713.00)

5108.00

(2213.509978.50)

< 0.001

β-hCG difference (mIU/ml)

17,562.10

(2945.7046044.62)

19,640.00

(9506.0054520.85)

17,305.00

(5929.1534914.25)

0.629

Rate of β-hCG decline (%)

91.73

(84.45 96.38)

86.46

(74.26 92.43)

78.07

(68.37 85.14)

< 0.001

Hospital time (days)

9.0 (7.0, 16.0)

3.0 (2.0 5.0)

4.0 (3.0 5.0)

< 0.001

Hospitalization expenses (¥)

13,677.50

(8240.75, 16,760.75)

4005.70

(3390.075632.22)

11,640.68

(10,746.3312684.02)

< 0.001

  1. Success treatment, surgery time, hospital time, hospitalization expenses, β-hCG after surgery, and rate of β-hCG decline (P < 0.05) were significantly different among these groups